G

Acushnet Holdings Corp.

GOLF NYSE Consumer Discretionary · Sporting & Athletic Goods, Nec Fairhaven, MA www.acushnetholdingscorp.com
$80.55
Mkt Cap 6.02B
We are the global leader in the design, development, manufacture and distribution of performance driven golf products, and these products are widely recognized for their quality excellence. Our missio…

We are the global leader in the design, development, manufacture and distribution of performance driven golf products, and these products are widely recognized for their quality excellence. Our mission to be the performance and quality leader in every golf product category in which we compete has remained consistent since we entered the golf ball business in 1932. Today, we are the steward of two of the most revered brands in golf Titleist, one of golf’s leading performance equipment brands, and FootJoy, one of golf’s leading performance wearable brands. Titleist has been the #1 ball in professional golf for over 75 years and FootJoy has been the #1 shoe on the PGA Tour for eight decades. Our target market is dedicated golfers, who are the cornerstone of the worldwide golf industry. These dedicated golfers are avid and skill biased, prioritize performance and commit the time, effort and money to improve their game. We believe our focus on innovation and process excellence yields golf products that represent superior performance and consistent product quality, which are the key attributes sought after by dedicated golfers. Many of the game’s professional players, who represent the most dedicated golfers, prefer our products, thereby validating our performance and quality promise while also driving brand awareness. We seek to leverage a pyramid of influence product and promotion strategy, whereby our products are the most played by the world’s best players, creating aspirational appeal for a broad range of golfers who want to emulate the performance of the game’s best players.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$2.71B
FCF TTM
$183.7M
P/E RATIO
27.4x
P/FCF
32.8x
Running full 6-factor analysis…